Diaz-Canel called to ensure stability in the Basic Drug Plan.

Diaz-Canel called to ensure stability in the Basic Drug Plan.

HAVANA, Cuba. – In the Annual balance of Biocubafarma Business Group, the President of the Councils of State and Ministers, Miguel Diaz-Canel Bermudez called to ensure stability in the Basic Drug Plan, continue working on import substitution, incorporate new products and enhance clinical tests.

We must export more, import less, diversify products and markets, as well as boost foreign investment and reinforce negotiating teams, the President insisted.

Diaz-Canel called, in the midst of complex situations, to continue developing investments to modernize productive processes and strengthen technological and logistics infrastructures.

In the annual balance of Biocubafarma, Diaz-Canel urged to defend productive linkages, to strengthen the links with the Universities and to continue developing without underestimating the products of natural origin.

Biocubafarma is a pride of the Revolution, President Miguel Diaz-Canel said, and stated that as many he is very proud of being Cuban regarding the contributions of the institution.

With you, he said, we can defend the conviction that in the face of the complex economic and financial situation and the threats we have, we will grow and conquer.